Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • frogsleapmerlot frogsleapmerlot Apr 17, 2003 11:01 AM Flag

    valuation

    Its all about the marketing label, Indiplon will have the broadest label of them all, Ambien only approved for short term use for sleep initiation only 7-10 days because of labeling issues, Indiplon will be for 6 months duration, sleep initiation, chronic insomnia, middle of the night awakening ectectect. its the label that counts not just the efficiency and safety of the compound. Indiplon will cannibolize Ambien sales in the first 18 months, current sales of over $1billion.

 
NBIX
34.71-0.66(-1.87%)11:17 AMEST